| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
PREVIOUS | 2
| 3
| 4
| 5
| 6
| 7
| 8
| 9
| 10
| 11
| 12
| 13
| 14
|
NEXT 
|
| Title |
Date |
Price |
|
The Novo-Nordisk A Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Novozymes A/S Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The NPS Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Nutra Pharma Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Nutraceutical International Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Oct, 2006 |
€375 |
|
The Nutrition 21 Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Nuvelo Inc New Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Premera family of companies provides health, dental, life and disability insurance to more than 1.55 million members in Washington, Alaska, Oregon and Arizona. The Premera family of companies provides... |
Sep, 2004 |
€369 |
|
The Nymox Pharmaceutical Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Jan, 2007 |
€375 |
|
The Oncolytics Biotech Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Ondine Biopharma Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Only You Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
The Onyx Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Oragenics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The OraSure Technologies Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Oct, 2006 |
€375 |
|
The Orchid Chemicals & Pharmaceuticals Ltd Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Jan, 2007 |
€375 |
|
The Ortec International Inc New Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Mar, 2006 |
€375 |
|
The OrthoLogic Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
Specialty pharmaceuticals are generally expensive, injectable therapies used to treat patients with chronic illnesses. Specialty drugs cost an average of $18,000 per year but may run as high as $350,000.... |
Nov, 2004 |
€369 |
|
The Orthovita Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
|
|
|
